AR and metastatic prostate carcinoma: Shortly thereafter, with distinct bioinformatics approaches, two other studies confirmed an attenuated androgen signaling signature in high-grade and metastatic prostate cancer, indicating that down-regulation of the AR pathway, although controversial, is likely to be a true phenomenon [49], [50].